Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Receivables (2016 - 2025)

Healthy Extracts' Receivables history spans 11 years, with the latest figure at $187750.0 for Q4 2025.

  • For Q4 2025, Receivables rose 1606.35% year-over-year to $187750.0; the TTM value through Dec 2025 reached $187750.0, up 1606.35%, while the annual FY2025 figure was $187750.0, 1606.35% up from the prior year.
  • Receivables reached $187750.0 in Q4 2025 per HYEX's latest filing, up from $31264.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $187750.0 in Q4 2025 to a low of $3980.0 in Q2 2025.
  • Average Receivables over 5 years is $76306.1, with a median of $87072.5 recorded in 2021.
  • The largest YoY upside for Receivables was 1606.35% in 2025 against a maximum downside of 95.61% in 2025.
  • A 5-year view of Receivables shows it stood at $133340.0 in 2021, then fell by 20.66% to $105794.0 in 2022, then crashed by 71.23% to $30440.0 in 2023, then tumbled by 63.85% to $11003.0 in 2024, then surged by 1606.35% to $187750.0 in 2025.
  • Per Business Quant, the three most recent readings for HYEX's Receivables are $187750.0 (Q4 2025), $31264.0 (Q3 2025), and $3980.0 (Q2 2025).